447 related articles for article (PubMed ID: 36652160)
21. Observational study on the QUality of life of Italian Axial SpondyloARthritis patients (QUASAR): baseline data.
D'Angelo S; Gilio M; D'Attino RM; Gualberti G; Merolla R; di Luzio Paparatti U; Malavolta N; Corvaglia S; Marchetta A; Scambi C; Romeo N; Pettiti G; Salvarani C; Catanoso MG; Scarpa R; Costa L; Ramonda R; Frallonardo P; Muratore M; Quarta L; Passiu G; Erre GL; Lubrano D; Tirri E; Govoni M; Furini F; Russo R; Buono R; Pozzi MR; Riva M; Grembiale RD; Bruno C; Gibertini P; Marchesoni A
Clin Exp Rheumatol; 2019; 37(5):748-755. PubMed ID: 30943145
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic controversies in spondyloarthritis: nonsteroidal anti-inflammatory drugs.
Poddubnyy D; van der Heijde D
Rheum Dis Clin North Am; 2012 Aug; 38(3):601-11. PubMed ID: 23083758
[TBL] [Abstract][Full Text] [Related]
23. Upadacitinib for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA).
Fukui S; Kawaai S; Sawada H; Kishimoto M
Expert Rev Clin Immunol; 2024 Feb; 20(2):141-153. PubMed ID: 37955181
[TBL] [Abstract][Full Text] [Related]
24. Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry.
Bodur H; Yurdakul FG; Ataman S; Cay HF; Gurer G; Capkin E; Sezer İ; Duruoz MT; Melikoglu MA; Rezvani A; Yagci I; Gogus F; Kamanli A; Akgul O; Cevik R
Clin Rheumatol; 2022 Jul; 41(7):2053-2063. PubMed ID: 35353263
[TBL] [Abstract][Full Text] [Related]
25. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.
van der Heijde D; Ramiro S; Landewé R; Baraliakos X; Van den Bosch F; Sepriano A; Regel A; Ciurea A; Dagfinrud H; Dougados M; van Gaalen F; Géher P; van der Horst-Bruinsma I; Inman RD; Jongkees M; Kiltz U; Kvien TK; Machado PM; Marzo-Ortega H; Molto A; Navarro-Compàn V; Ozgocmen S; Pimentel-Santos FM; Reveille J; Rudwaleit M; Sieper J; Sampaio-Barros P; Wiek D; Braun J
Ann Rheum Dis; 2017 Jun; 76(6):978-991. PubMed ID: 28087505
[TBL] [Abstract][Full Text] [Related]
26. Developments in therapies for spondyloarthritis.
Sieper J
Nat Rev Rheumatol; 2012 Apr; 8(5):280-7. PubMed ID: 22487798
[TBL] [Abstract][Full Text] [Related]
27. Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis.
Baraliakos X; Kiltz U; Peters S; Appel H; Dybowski F; Igelmann M; Kalthoff L; Krause D; Menne HJ; Saracbasi-Zender E; Schmitz-Bortz E; Vigneswaran M; Braun J
Rheumatology (Oxford); 2017 Jan; 56(1):95-102. PubMed ID: 27997346
[TBL] [Abstract][Full Text] [Related]
28. Biologic disease-modifying anti-rheumatic drugs and patient-reported outcomes in axial SpA: a systematic review and a call for action.
Rodrigues-Manica S; Silva J; Cruz-Machado R; Coelho C; Duarte J; Vieira-Sousa E; Tavares-Costa J; Pimentel-Santos FM
Clin Rheumatol; 2021 Jan; 40(1):33-41. PubMed ID: 32533340
[TBL] [Abstract][Full Text] [Related]
29. Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis.
Bautista-Molano W; Fernández-Ávila DG; Brance ML; Ávila Pedretti MG; Burgos-Vargas R; Corbacho I; Cosentino VL; Díaz Coto JF; Giraldo Ho E; Gomes Resende G; Gutiérrez LA; Gutiérrez M; Ibáñez Vodnizza SE; Jáuregui E; Ocampo V; Palleiro Rivero DR; Palominos PE; Pacheco Tena C; Quiceno GA; Saldarriaga-Rivera LM; Sommerfleck FA; Goecke Sariego A; Vera Barrezueta C; Vega Espinoza LE; Vega Hinojosa O; Citera G; Lozada C; Sampaio-Barros PD; Schneeberger E; Soriano ER
Nat Rev Rheumatol; 2023 Nov; 19(11):724-737. PubMed ID: 37803079
[TBL] [Abstract][Full Text] [Related]
30. Treatment challenges in axial spondylarthritis and future directions.
Sieper J
Curr Rheumatol Rep; 2013 Sep; 15(9):356. PubMed ID: 23888365
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Non-radiographic Axial Spondyloarthritis and Ankylosing Spondyltis from a Single Rheumatology Hospital in Morocco.
Akasbi N; Nihad S; Sofia Z; Khadija EK; Taoufik H
Curr Rheumatol Rev; 2020; 16(3):240-244. PubMed ID: 30806321
[TBL] [Abstract][Full Text] [Related]
32. New evidence on the management of spondyloarthritis.
Sieper J; Poddubnyy D
Nat Rev Rheumatol; 2016 May; 12(5):282-95. PubMed ID: 27052489
[TBL] [Abstract][Full Text] [Related]
33. The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.
Deodhar A; Strand V; Kay J; Braun J
Ann Rheum Dis; 2016 May; 75(5):791-4. PubMed ID: 26768406
[TBL] [Abstract][Full Text] [Related]
34. Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs.
Al Mohamad F; Rios Rodriguez V; Haibel H; Protopopov M; Rademacher J; Sieper J; Torgutalp M; Käding H; Proft F; Poddubnyy D
RMD Open; 2024 Feb; 10(1):. PubMed ID: 38360039
[TBL] [Abstract][Full Text] [Related]
35. Nonsteroidal Antiinflammatory Drugs as Potential Disease-Modifying Medications in Axial Spondyloarthritis.
Wang R; Bathon JM; Ward MM
Arthritis Rheumatol; 2020 Apr; 72(4):518-528. PubMed ID: 31705611
[TBL] [Abstract][Full Text] [Related]
36. Circulating cell-free DNA correlate to disease activity and treatment response of patients with radiographic axial spondyloarthritis.
Peng Y; Wu Y; Chen S; Liu Y; Qian H; He Y; Huang H; Cai M; Liu W; Shi G
Sci Rep; 2024 Jan; 14(1):178. PubMed ID: 38168507
[TBL] [Abstract][Full Text] [Related]
37. Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation.
Corbett M; Soares M; Jhuti G; Rice S; Spackman E; Sideris E; Moe-Byrne T; Fox D; Marzo-Ortega H; Kay L; Woolacott N; Palmer S
Health Technol Assess; 2016 Feb; 20(9):1-334, v-vi. PubMed ID: 26847392
[TBL] [Abstract][Full Text] [Related]
38. Non-steroidal anti-inflammatory drug use is determined by disease activity in axSpA and decreased by biologicals: a longitudinal analysis.
Durak Ediboğlu E; Solmaz D; Kabadayı G; Gücenmez S; Cinakli H; Otman Akat E; Özmen M; Akar S
ARP Rheumatol; 2023; 2(4):322-329. PubMed ID: 38174752
[TBL] [Abstract][Full Text] [Related]
39. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
[TBL] [Abstract][Full Text] [Related]
40. Nonradiographic axial spondyloarthritis: expanding the spectrum of an old disease: A narrative review.
Magrey M; Schwartzman S; de Peyrecave N; Sloan VS; Stark JL
Medicine (Baltimore); 2022 Apr; 101(15):e29063. PubMed ID: 35475794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
